Similarly, the BCR::ABL1 fusion in CML functions via constitutive kinase activation, which in turn drives proliferation by enhancing downstream signaling pathways [151,152,153]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.